Investigation of the Bioactive Conformation of Histamine H_3 ReceptorAntagonists by the Cyclopropylic Strain-Based Conformational Restriction Strategy
Investigation of the Bioactive Conformation of Histamine H_3 ReceptorAntagonists by the Cyclopropylic Strain-Based Conformational Restriction Strategy
复制标题
基于环丙基菌株的构象限制策略研究组胺H_3受体拮抗剂的生物活性构象
DOI:
10.1021/jm901848b
复制
发表时间:
2010
期刊:
影响因子:
--
通讯作者:
S. Shuto
中科院分区:
文献类型:
--
作者:
M. Watanabe;T. Hirokawa;T. Kobayashi;A. Yoshida;Y. Ito;S. Yamada;N. Orimoto;Y. Yamasaki;M. Arisawa;S. Shuto
We previously identified the highly potent histamine H3receptor antagonists (1R,2S)-2-[2-(4-chlorobenzylamino)ethyl]-1-(1H-imidazol-4-yl)cyclopropane (1) and its enantiomerent-1. Although the conformations of1andent-1are restricted by the central cyclopropane ring, the 2-(4-chlorobenzylamino)ethyl side chain essential for the H3receptor binding may somewhat freely rotate. To investigate the bioactive conformation, the 1′-ethyl-substituted derivatives2aand2band their enantiomersent-2aandent-2bwere designed as side chain conformation-restricted analogues of1andent-1, based on the cyclopropylic strain. These compounds were synthesized, and their analysis by NMR and calculations suggested that the side chain moiety was effectively restricted in asyn-form or ananti-form by the cyclopropylic strain as expected. Pharmacological evaluation and docking simulation showed that the bioactive conformations of1andent-1appear to be thesyn-form and theanti-form, respectively. Thus, the cyclopropylic strain can be effectively used for conformational restriction of the side chain moiety of cyclopropane compounds.